Characterization of a Mouse Model for Thrombomodulin Deficiency
Hartmut Weiler(Medical College of Wisconsin), Jeffrey I. Weitz(McMaster University Medical Centre), Laurien H. Ulfman(FrieslandCampina (Netherlands)), Nicholas W. Shworak(Maine Medical Center), Ulrich H. von Andrian(Harvard University), David A. Meh(Maine Medical Center), Brian C. Cooley, Sara B. Hendrickson(Maine Medical Center), Edward M. Conway(University of British Columbia), Volkhard Lindner(MaineHealth), Berend Isermann(Leipzig University), Bryce A. Kerlin(Nationwide Children's Hospital), Michael W. Mosesson(State University of New York), Mark J. Post(Maastricht University)
Cited by 144
Related Papers
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k
Vitamin effects on the immune system: vitamins A and D take centre stage
|Nature reviews. Immunology|2008|1.6k